IBDEI3J6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2849,0)
 ;;=COMMON VASCULAR DX^1^264
 ;;^UTILITY(U,$J,358.4,2850,0)
 ;;=ABDOMINAL PAIN^2^264
 ;;^UTILITY(U,$J,358.4,2851,0)
 ;;=AFTERCARE POST SURGERY^3^264
 ;;^UTILITY(U,$J,358.4,2852,0)
 ;;=CARDIOVASCULAR^4^264
 ;;^UTILITY(U,$J,358.4,2853,0)
 ;;=METASTATIC CANCER SITES^5^264
 ;;^UTILITY(U,$J,358.4,2854,0)
 ;;=POST-OP COMPLICATIONS^6^264
 ;;^UTILITY(U,$J,358.4,2855,0)
 ;;=RESPIRATORY^8^264
 ;;^UTILITY(U,$J,358.4,2856,0)
 ;;=SIGNS & SYMPTOMS^9^264
 ;;^UTILITY(U,$J,358.4,2857,0)
 ;;=PRE-OP^7^264
 ;;^UTILITY(U,$J,358.4,2858,0)
 ;;=NEW PATIENT^2^265
 ;;^UTILITY(U,$J,358.4,2859,0)
 ;;=ESTABLISHED PATIENT^1^265
 ;;^UTILITY(U,$J,358.4,2860,0)
 ;;=CONSULTATIONS^3^265
 ;;^UTILITY(U,$J,358.4,2861,0)
 ;;=POST-OP F/U VISIT^5^265
 ;;^UTILITY(U,$J,358.4,2862,0)
 ;;=GYN PROCEDURES^1^266
 ;;^UTILITY(U,$J,358.4,2863,0)
 ;;=INJECTIONS^11^266
 ;;^UTILITY(U,$J,358.4,2864,0)
 ;;=INJECTION ADMINISTRATION^10^266
 ;;^UTILITY(U,$J,358.4,2865,0)
 ;;=EAR WAX REMOVAL^5^266
 ;;^UTILITY(U,$J,358.4,2866,0)
 ;;=CARDIAC^2^266
 ;;^UTILITY(U,$J,358.4,2867,0)
 ;;=FOREIGN BODY^8^266
 ;;^UTILITY(U,$J,358.4,2868,0)
 ;;=UA/FINGERSTICK^15^266
 ;;^UTILITY(U,$J,358.4,2869,0)
 ;;=FLUSHES^6^266
 ;;^UTILITY(U,$J,358.4,2870,0)
 ;;=TB TEST^14^266
 ;;^UTILITY(U,$J,358.4,2871,0)
 ;;=DRAIN/INJECT JOINT^4^266
 ;;^UTILITY(U,$J,358.4,2872,0)
 ;;=DESTRUCTION OF LESIONS^3^266
 ;;^UTILITY(U,$J,358.4,2873,0)
 ;;=IMMUNIZATIONS^9^266
 ;;^UTILITY(U,$J,358.4,2874,0)
 ;;=IMMUNIZATION ADMINISTRATION^8^266
 ;;^UTILITY(U,$J,358.4,2875,0)
 ;;=PREVENTIVE MED-EST PT^12^266
 ;;^UTILITY(U,$J,358.4,2876,0)
 ;;=PREVENTIVE MED-NEW PT^13^266
 ;;^UTILITY(U,$J,358.4,2877,0)
 ;;=GENITOURINARY & RENAL^5^267
 ;;^UTILITY(U,$J,358.4,2878,0)
 ;;=GYNECOLOGICAL/BREAST^6^267
 ;;^UTILITY(U,$J,358.4,2879,0)
 ;;=CARDIO/VASCULAR^1^267
 ;;^UTILITY(U,$J,358.4,2880,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITION^2^267
 ;;^UTILITY(U,$J,358.4,2881,0)
 ;;=EYES/EARS/NOSE^3^267
 ;;^UTILITY(U,$J,358.4,2882,0)
 ;;=GASTROINTESTINAL^4^267
 ;;^UTILITY(U,$J,358.4,2883,0)
 ;;=MUSCULOSKELETAL^9^267
 ;;^UTILITY(U,$J,358.4,2884,0)
 ;;=NEUROLOGY^10^267
 ;;^UTILITY(U,$J,358.4,2885,0)
 ;;=PULMONARY^11^267
 ;;^UTILITY(U,$J,358.4,2886,0)
 ;;=PSYCHIATRIC^12^267
 ;;^UTILITY(U,$J,358.4,2887,0)
 ;;=SKIN^13^267
 ;;^UTILITY(U,$J,358.4,2888,0)
 ;;=IMMUNIZATIONS^7^267
 ;;^UTILITY(U,$J,358.4,2889,0)
 ;;=MISCELLANEOUS^8^267
 ;;^UTILITY(U,$J,358.4,2890,0)
 ;;=WOUND OSTOMY CARE^1^268
 ;;^UTILITY(U,$J,358.4,2891,0)
 ;;=NEW PATIENT^2^269
 ;;^UTILITY(U,$J,358.4,2892,0)
 ;;=ESTABLISHED PATIENT^1^269
 ;;^UTILITY(U,$J,358.4,2893,0)
 ;;=CONSULTATIONS^3^269
 ;;^UTILITY(U,$J,358.4,2894,0)
 ;;=WOUNDS^1^270
 ;;^UTILITY(U,$J,358.4,2895,0)
 ;;=ARTIFICIAL OPENING^2^270
 ;;^UTILITY(U,$J,358.4,2896,0)
 ;;=DIABETES^3^270
 ;;^UTILITY(U,$J,358.4,2897,0)
 ;;=PRESSURE ULCER^4^270
 ;;^UTILITY(U,$J,358.4,2898,0)
 ;;=SUTURE/DRESSING^5^270
 ;;^UTILITY(U,$J,358.4,2899,0)
 ;;=TELERETINAL PROCEDURES^1^271
 ;;^UTILITY(U,$J,358.4,2900,0)
 ;;=ANTERIOR SEGMENT^2^272
 ;;^UTILITY(U,$J,358.4,2901,0)
 ;;=GLAUCOMA^4^272
 ;;^UTILITY(U,$J,358.4,2902,0)
 ;;=INFECTIONS^5^272
 ;;^UTILITY(U,$J,358.4,2903,0)
 ;;=LENS/CATARACT^6^272
 ;;^UTILITY(U,$J,358.4,2904,0)
 ;;=LOW VISION/BLINDNESS^7^272
 ;;^UTILITY(U,$J,358.4,2905,0)
 ;;=DIABETES^3^272
 ;;^UTILITY(U,$J,358.4,2906,0)
 ;;=MOST COMMON & POST OP^1^272
 ;;^UTILITY(U,$J,358.4,2907,0)
 ;;=NEUROLOGIC EYE DISEASE^8^272
 ;;^UTILITY(U,$J,358.4,2908,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^272
 ;;^UTILITY(U,$J,358.4,2909,0)
 ;;=REFRACTION^10^272
 ;;^UTILITY(U,$J,358.4,2910,0)
 ;;=RETINA/VITREOUS^11^272
 ;;^UTILITY(U,$J,358.4,2911,0)
 ;;=STRABISMUS^12^272
